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BRIEF DEFINITIVE REPORT T lymphocytes were isolated from 48-h macro or bulk cultures by velocity sedimentation on Percoll gradients (6) . Clusters that contained the antigen-reactive T cells were recultured at 2-6 x 105/ml in 1 or 10 ml cultures for an additional 48 h; i.e., 48-96 h of the 1°MLR . Supernatants were harvested at the indicated time points and assayed for lymphokines . Simultaneously, 100-wl aliquots of the resuspended cultures were transferred to microtiter wells and pulsed for 8 h with 1 R Ci/well [3H]thymidine . For the 2°MLR, T blasts were generated by DC-T clusters, isolated at 48 h of the primary MLR, and recultured until 96 h. The blasts were separated from residual clusters (6) and then depleted of residual Ia' stimulator cells and contaminating CD4' or CD8' T cells with mAb and C. T blasts were recultured at 2-5 x 105/ml with the various irradiated stimulator populations at the indicated ratios.
Lymphokines . Recombinant human IL-2 (r-huIL-2) was provided by Dr. S. Rudnick (Biogen, Cambridge, MA) . r-muIL-4 was purified on an 111111 anti-IL-4 (provided by Dr. E. S. Vitetta, Dallas, TX) affinity column from the conditioned medium of an IL-4-transferred HeLa cell line (provided by Dr. T. Honjo, Kyoto, Japan).
Lymphokine Assays . IL-4. IL-4 was detected by two different bioassays using r-muIL-4 as a positive control in both cases . One was the costimulation assay in which IL-4 and anti-Ig together induce [3H]TdR incorporation in high density or unfructionated murine B cells as described (9) . The identity of the active factor was confirmed by inhibiting the response with 2-10 ug/ml 11BIl anti-IL-4 mAb (10). The second bioassay was the growth of the CTLL cell line seeded at 5 x 103 cells per well in a final volume of 100 pl. Although CTLL is used for IL-2 bioassays, our cell line also responds to r-muIL-4 . The maximal proliferative response ofCTLL cells to rIL-4 was much lower than the maximal response to rIL-2, but was specifically inhibited by 11B11 anti-IL-4 and not by S4B6 anti-IL-2 .
IL-2 . IL-2 was detected by its ability to maintain the growth of CTLL cells . Inhibition by the anti-IL-2 mAb S4B6 (11) (provided by Dr. T Mossman, DNAX, Palo Alto, CA) was used to distinguish the contribution ofmurine IL-2 and other possible T cell growth factors that might register in this assay. r-huIL-2 was used as a positive control .
BCGFAssay. Anti-Ig-activated B lymphoblasts proliferate and secrete Ig in response to reculture in the presence of T cell-derived lymphokines distinct from IL-1, 2, 3, and 4 (4) . An ammonium sulfate fraction (50-85%) ofconditioned medium from PMA-stimulated EL-4 cells was used as a positive control . We have recently determined that neither purified natural IL-5 (provided by Drs. D. MacKenzie and S. Swain, UCSD, University of California, San Diego, CA) nor rIL-5 (present in the supernatant of IL-5 COS cell transfectants) alone can substitute for EL-4 Sn in this assay (E. Pure, unpublished results). We refer to this activity as BCGE The response induced by EL-4 Sri or MLR Sri in this assay was inhibited by at most 20% by anti-IL-2 or anti-IL-4 or both, confirming that the factor(s) detected by the growth of preactivated anti-19 blasts is distinct from IL-2 or IL-4.
Results and Discussion Kinetics ofIL-2, IL-4, and BCGF Production by CD4' Tcells in the MLR . IL-2 was consistently detected in the media of a 1°MLR as early as 4 h (Fig. 1 A) . IL-2 levels increased for the first 48 h and remained high for at least 96 h. S4B6 anti-IL-2 completely inhibited the CTLL response to MLR medium collected during the first 2 d, but the mAb blocked only 40-60% at later time points . Incomplete inhibition oflater supernatants could be due to the production of IL-2 in excess ofthe amount that could be neutralized by the dose of S4B6 used, or another T cell growth factor. Since 11BIl anti-IL-4 had no effect when the 1°MLR Sri was tested on CTLL, and inhibition by 11B11 plus S4B6 was similar to S4B6 alone, the S4116-resistant activity cannot be attributed to IL-4 . T blasts were isolated from the 1°MLR and restimulated with fresh DC in a 2°MLR . Large quantities of IL-2, maximal by 12 h, were detectable in the medium of this 2°MLR (Fig. 1 A, rightpanel) . S4B6 blocked much of this activity and 111111 enhanced the block. IL-2, IL-4, and BCGF production by CD4' T cells during the 1°and 2°MLR. 5 x 10 6/ml CxD2Fl CD4* T cells were cultured "in bulk" with 5 x 10 4 B6 .H-2k DC in 1 ml for 48 h. Clusters were harvested and recultured at 5 x 10 5/ml. T blasts were harvested at 96 h and restimulated at 5 x 105/ml with 104 DC or 5 x 10 4 anti-Ig blasts in the 2°MLR. Cell-free supernatants were harvested at the indicated times, and 100 pl aliquots of resuspended cells from the same wells were transferred to microtiter wells to be pulsed with 1 RCi The anti-Ig costimulation assay, in contrast to the CTLL assay which is an insensitive measure of IL-4, detected IL-4 in the 1°MLR Sn . Activity was first noted after the first day and was present for the remainder of the 96 h (Fig . 1 B) . The maximal amount of IL-4 detected in the 1°MLR, by comparison with the doseresponse curve obtained with r-muIL-4, was 2-10 U/ml in three experiments. The quantity of IL-4 was markedly higher in the 2°MLR Sin (Fig . 1 B) , reaching a peak of 100 U/ml by 12 h. The activity of the 1°and 2°MLR media in the anti-Ig IL-4 costimulation assay was completely inhibited by 11B11 anti-IL-4 ( Fig. 1 B) but was decreased by at most 20% by S4B6 anti-IL-2 (data not shown) .
Finally, MLR supernatants were assayed for BCGF activity on preactivated antiIg blasts (Fig. 1 C) . BCGF was found in small but detectable quantities by 24 h 798 PURE ET AL .
BRIEF DEFINITIVE REPORT in the 1°MLR (Fig. 1 C, left panel) . In contrast to IL-4, the BCGF activity increased throughout the next 72 h (Fig . 1 C, center panel) . Large quantities of BCGF, comparable with those found late during the 1°MLR, were detected in the conditioned media by 12 h of the 2°MLR (Fig. 1 C, right panel) . The response of anti-Ig preactivated blasts was not inhibited at all by 11B11 and at most by 20% in the presence of S4B6 (not shown) .
Lymphokine production required T cell stimulation in the MLR. First, the induction oflymphokines was blocked by mAb to the MHC class II antigens expressed on the stimulator population . The mAb did not interfere with the lymphokine bioassays . Second, in all experiments, supernatants from control cultures of stimulator cells alone or fresh responder T cells alone lacked detectable levels of IL-2, IL-4, or BCGF.
The low levels of IL-4 detected in the conditioned medium of the primary MLR may either reflect low levels of production, rapid consumption by the activated T cells that may use IL-4 as a growth factor (12) , or the production of factors, for example IFN -1', that inhibit IL-4 activity in the assay.
Comparison of IL-4 and BCGF Production by CD8' and CD4+ TBlasts . Inaba et al. (7) have reported that allogeneic DC induced the release of IL-2 by both CD4' and CD8+ lymphocyte subsets. We therefore assayed the conditioned medium from Lyt-2 -(CD4+) or L3T4 -(CD8') MLRs for IL-4 and BCGF activity (Fig. 2) . Conditioned medium from CD4' cultures contained IL-4 ( Fig. 2 A) and BCGF (Fig. 2  B) by 24 h with maximal levels at 48 h (Fig. 2) . The production of IL-4 and BCGF was inhibited by the presence of anti-L3T4 antibody during the MLR (data not shown) . In contrast, only low levels of IL-4 and BCGF activity were detected in the conditioned media of the CD8+ MLR (Fig. 2) . Identification of IL-4 and IL-2 in the 2°MLR-conditioned medium . CxD2F1 CD4T blasts were restimulated by B6.h-2k DC or 48-h anti-Ig blasts as in Fig. 1 . At 24 h, the medium was taken and assayed for IL-4 in the anti-Ig costimulation assay (A) and in the CTLL assay (B). IL-4 and IL-2 activities were confirmed by comparing the responses in the presence or absence of 2 gg/ml 111311 anti-IL-4, 25% S4B6 anti-IL-2 culture supernatant, or both . phokine production (data not shown) . The pattern of stimulation in the 2°MLR was different. Small B cells did induce IL-2, IL-4, and BCGF production by allogeneic T blasts, although they were less efficient then anti-Ig blasts or DC (Fig. 3 and data not shown) . Consistent with the reported irradiation sensitivity of B cell accessory function (13), treatment with 3,000 rad blocked the capacity ofB cells, but not antiIg blasts or DC, to induce lymphokine release (data not shown) . Interestingly, antiIg blasts were reproducibly as, or more, effective than DC at stimulating lymphokine production in the 2°MLR (Fig. 3) .
Summary
Although the production ofB cell stimulatory factors by cell lines and hybridomas is well established, production of specific lymphokines by normal T cells in response to antigen stimulation has not been analyzed. We have used bioassays and neutralizing mAbs to demonstrate that IL-2, IL-4, and B cell growth factors (BCGF) are produced during primary and secondary MLRs. IL-2 is detected in the first 12 h of both types of MLR. IL-4 and BCGF appear at 24-48 h in the conditioned medium of the primary MLR, and peak by 12 h in the secondary MLR. The amount of IL-4 in the primary response reaches a level that is 10% of that detected in the secondary. In contrast, BCGF production steadily increases over time in the primary MLR, and maximal production is equivalent to that made in the secondary response . Allogeneic dendritic cells and anti-Ig-activated B blasts both stimulated lymphokine production in the primary MLR, whereas small B cells were weak. In the secondary MLR, all three cell populations stimulated the production of IL-2, IL-4, and BCGF. Therefore, the release of several defined B cell stimulating factors can be detected in the conditioned media of responding primary T lymphocytes.
